dr. overman on ongoing research with immunotherapy in mss crc
Published 4 years ago • 146 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:38
dr. overman on remaining questions with immunotherapy in crc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
1:37
dr. overman on next steps with immunotherapy in mcrc
-
1:15
dr. overman discusses progress with immunotherapy in gi cancer
-
1:31
dr. michael j. overman on immunotherapy in colorectal cancer
-
3:27
crc: emerging immunotherapy strategies in mss tumors
-
0:58
dr. overman discusses immunotherapy and msi testing in crc
-
1:09
dr. mccollum on immunotherapy in mss crc
-
1:46
dr. overman on investigational targeted therapies in mcrc
-
1:18
dr. overman on unmet needs with immunotherapy in mcrc
-
2:00
dr. overman on nivolumab and ipilimumab in patients with msi-h crc
-
5:48
emerging immunotherapy combinations in mss crc
-
0:46
key limitations of current treatment options for patients with mss-crc
-
1:20
dr. fakih on immunotherapy in mss colon cancer
-
2:15
dr. overman discusses redos study in mcrc
-
6:11
immunotherapy in crc
-
3:17
immunotherapy in mss colorectal cancer
-
1:29
com701 & nivolumab in patients with metastatic mss-crc & liver metastases
-
1:07
dr. eng on ongoing studies for braf-mutant crc